Russia Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Summary
GlobalData’s new report, Russia Drug Delivery Devices Market Outlook to 2023, provides key market data on the Russia Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the Russia Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
- 1 Table of Contents 2
- 1.1 List of Tables 5
- 1.2 List of Figures 6
- 2 Introduction 7
- 2.1 What Is This Report About? 7
- 2.2 Drug Delivery Devices Market Segmentation 7
- 2.3 Definitions of Markets Covered in the Report 8
- 3 Drug Delivery Devices Market, Russia 11
- 3.1 Drug Delivery Devices Market, Russia, Revenue ($m), 2009-2023 11
- 3.2 Drug Delivery Devices Market, Russia, Revenue Mix ($m), 2016 13
- 3.3 Drug Delivery Devices Market, Russia, Category Contribution by Revenue ($m), 2016 14
- 3.4 Drug Delivery Devices Market, Russia, Category Comparison by Revenue ($m), 2009-2023 15
- 3.5 Drug Delivery Devices Market, Russia, Revenue ($m), 2009-2016 16
- 3.6 Drug Delivery Devices Market, Russia, Revenue ($m), 2016-2023 18
- 3.7 Drug Delivery Devices Market, Russia, Volume (Units), 2009-2023 20
- 3.8 Drug Delivery Devices Market, Russia, Volume (Units), 2009-2016 22
- 3.9 Drug Delivery Devices Market, Russia, Volume (Units), 2016-2023 24
- 3.10 Drug Delivery Devices Market, Russia, Company Share by Revenue ($m), 2016 26
- 4 Central Venous Catheters Market, Russia 28
- 4.1 Central Venous Catheters Market, Russia, Revenue Mix ($m), 2016 28
- 4.2 Central Venous Catheters Market, Russia, Segment Contribution (%), 2016 29
- 4.3 Central Venous Catheters Market, Russia, Revenue ($m), 2009-2016 30
- 4.4 Central Venous Catheters Market, Russia, Revenue ($m), 2016-2023 32
- 4.5 Central Venous Catheters Market, Russia, Volume (Units), 2009-2016 34
- 4.6 Central Venous Catheters Market, Russia, Volume (Units), 2016-2023 36
- 4.7 Central Venous Catheters Market, Russia, Distribution Share by Revenue ($m), 2015-2016 38
- 4.8 Central Venous Catheters Market, Russia, Company Share by Revenue ($m), 2016 39
- 5 Infusion Systems Market, Russia 41
- 5.1 Infusion Systems Market, Russia, Revenue Mix ($m), 2016 41
- 5.2 Infusion Systems Market, Russia, Segment Contribution (%), 2016 42
- 5.3 Central Venous Catheters Market, Russia, Revenue ($m), 2009-2016 43
- 5.4 Central Venous Catheters Market, Russia, Revenue ($m), 2016-2023 45
5.5 Central Venous Catheters Market, Russia, Volume (Units), 2009-2016 47- 5.6 Central Venous Catheters Market, Russia, Volume (Units), 2016-2023 49
5.7 Central Venous Catheters Market, Russia, Distribution Share by Revenue ($m), 2015-2016 51- 5.8 Central Venous Catheters Market, Russia, Company Share by Revenue ($m), 2016 52
- 6 Metered Dose Inhaler Devices Market, Russia 54
- 6.1 Metered Dose Inhaler Devices Market, Russia, Revenue ($m), 2009-2016 54
- 6.2 Metered Dose Inhaler Devices Market, Russia, Revenue ($m), 2016-2023 55
- 6.3 Metered Dose Inhaler Devices Market, Russia, Volume (Units), 2009-2016 56
- 6.4 Metered Dose Inhaler Devices Market, Russia, Volume (Units), 2016-2023 57
- 6.5 Metered Dose Inhaler Devices Market, Russia, Distribution Share by Revenue ($m), 2015-2016 58
- 6.6 Metered Dose Inhaler Devices Market, Russia, Company Share by Revenue ($m), 2016 59
- 7 Needle Free Injections Market, Russia 61
- 7.1 Needle Free Injections Market, Russia, Revenue ($m), 2009-2016 61
- 7.2 Needle Free Injections Market, Russia, Revenue ($m), 2016-2023 62
- 7.3 Needle Free Injections Market, Russia, Volume (Units), 2009-2016 63
- 7.4 Needle Free Injections Market, Russia, Volume (Units), 2016-2023 64
- 7.5 Needle Free Injections Market, Russia, Distribution Share by Revenue ($m), 2015-2016 65
- 7.6 Needle Free Injections Market, Russia, Company Share by Revenue ($m), 2016 66
- 8 Overview of Key Companies in Russia, Drug Delivery Devices Market 68
- 8.1 Teleflex Inc 68
8.1.1 Company Overview 68
8.2 B. Braun Melsungen AG 688.2.1 Company Overview 68
8.3 GlaxoSmithKline Plc 688.3.1 Company Overview 68
8.4 Baxter International Inc 688.4.1 Company Overview 68
8.5 AstraZeneca Plc 698.5.1 Company Overview 69
8.6 Boehringer Ingelheim GmbH 698.6.1 Company Overview 69
8.7 Fresenius Kabi AG 698.7.1 Company Overview 69
8.8 Medtronic Plc 698.8.1 Company Overview 69
8.9 Pfizer Inc 708.9.1 Company Overview 70
8.10 Merck & Co Inc 708.10.1 Company Overview 70
8.11 Becton Dickinson and Co 708.11.1 Company Overview 70
8.12 Smiths Medical 718.12.1 Company Overview 71
8.13 Hospira Inc 718.13.1 Company Overview 71
8.14 Teva Pharmaceutical Industries Ltd 718.14.1 Company Overview 71
8.15 Terumo Corp 71- 8.15.1 Company Overview 71
- 9 Drug Delivery Devices Market Pipeline Products 72
- 10 Financial Deals Landscape 77
- 10.1 Asset Transactions 77
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 77
10.2 Partnerships 7910.2.1 Alimera Sciences Enters into Licensing Agreement with pSivida 79
- 10.2.2 Bluegrass Vascular Enters into Partnership with Merit Medical 80
- 10.2.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 81
- 10.2.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 82
- 10.2.5 Propeller Health Enters into Agreement with Novartis Pharma 84
- 10.2.6 Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 85
- 10.2.7 Pfizer Terminates its Licensing Agreement with pSivida 86
- 10.2.8 Clinigen Group Enters into Distribution Agreement with BioQ Pharma 87
- 10.2.9 Bayer Enters into Licensing Agreement with DelSiTech 88
- 10.2.10 BioCorRx Enters into Licensing Agreement with Therakine 89
- 11 Recent Developments 90
- 11.1 Corporate Communications 90
11.1.1 Nov 09, 2016: Clearside Biomedical names Rick McElheny as Vice President, Business Development 90
11.2 Strategy And Business Planning 9011.2.1 Aug 09, 2016: Hitachi Medical Releases Major Upgrade to Oasis 1.2T Open MR 90
- 12 Appendix 92
- 12.1 Research Methodology 93
12.1.1 Coverage 93
- 12.1.2 Secondary Research 93
- 12.1.3 Primary Research 94
- 12.1.4 Company Share Analysis 94
- 12.1.5 Distribution Share Analysis 94
- 12.1.6 Benchmarking 95
12.2 GlobalData Consulting 95- 12.3 Contact Us 96
- 12.4 Disclaimer 96
- 1.1 List of Tables
- Table 1: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, 2009-2023 12
- Table 2: Drug Delivery Devices Market, Russia, Category Contribution by Revenue ($m), 2016 14
- Table 3: Drug Delivery Devices Market, Russia, Category Comparison by Revenue ($m), 2009-2023 15
- Table 4: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 17
- Table 5: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 19
- Table 6: Drug Delivery Devices Market, Russia, Volume (Units), 2009-2023 21
- Table 7: Drug Delivery Devices Market, Russia, Volume (Units), Historic, 2009-2016 23
- Table 8: Drug Delivery Devices Market, Russia, Volume (Units), Forecast, 2016-2023 25
- Table 9: Drug Delivery Devices Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 27
- Table 10: Central Venous Catheters Market, Russia, Segment Contribution (%), 2016 29
- Table 11: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 31
- Table 12: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 33
- Table 13: Central Venous Catheters Market, Russia, Volume (Units), Historic, 2009-2016 35
- Table 14: Central Venous Catheters Market, Russia, Volume (Units), Forecast, 2016-2023 37
- Table 15: Central Venous Catheters Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38
- Table 16: Central Venous Catheters Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 40
- Table 17: Infusion Systems Market, Russia, Segment Contribution (%), 2016 42
- Table 18: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 44
- Table 19: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 46
- Table 20: Central Venous Catheters Market, Russia, Volume (Units), Historic, 2009-2016 48
- Table 21: Central Venous Catheters Market, Russia, Volume (Units), Forecast, 2016-2023 50
- Table 22: Central Venous Catheters Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 51
- Table 23: Central Venous Catheters Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 53
- Table 24: Metered Dose Inhaler Devices Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 54
- Table 25: Metered Dose Inhaler Devices Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 55
- Table 26: Metered Dose Inhaler Devices Market, Russia, Volume (Units), Historic, 2009-2016 56
- Table 27: Metered Dose Inhaler Devices Market, Russia, Volume (Units), Forecast, 2016-2023 57
- Table 28: Metered Dose Inhaler Devices Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 58
- Table 29: Metered Dose Inhaler Devices Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 60
- Table 30: Needle Free Injections Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 61
- Table 31: Needle Free Injections Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 62
- Table 32: Needle Free Injections Market, Russia, Volume (Units), Historic, 2009-2016 63
- Table 33: Needle Free Injections Market, Russia, Volume (Units), Forecast, 2016-2023 64
- Table 34: Needle Free Injections Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 65
- Table 35: Needle Free Injections Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 67
- Table 36: Drug Delivery Devices Market Pipeline Products 72
- Table 37: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 77
- Table 38: Alimera Sciences Enters into Licensing Agreement with pSivida 79
- Table 39: Bluegrass Vascular Enters into Partnership with Merit Medical 80
- Table 40: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 81
- Table 41: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 82
- Table 42: Propeller Health Enters into Agreement with Novartis Pharma 84
- Table 43: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 85
- Table 44: Pfizer Terminates its Licensing Agreement with pSivida 86
- Table 45: Clinigen Group Enters into Distribution Agreement with BioQ Pharma 87
- Table 46: Bayer Enters into Licensing Agreement with DelSiTech 88
- Table 47: BioCorRx Enters into Licensing Agreement with Therakine 89
- 1.2 List of Figures
- Figure 1: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, 2009-2023 11
- Figure 2: Drug Delivery Devices Market, Russia, Revenue Mix ($m), 2016 13
- Figure 3: Drug Delivery Devices Market, Russia, Category Contribution (%), 2016 14
- Figure 4: Drug Delivery Devices Market, Russia, Category Comparison by Revenue ($m), 2009-2023 15
- Figure 5: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 16
- Figure 6: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 18
- Figure 7: Drug Delivery Devices Market, Russia, Volume (Units), 2009-2023 20
- Figure 8: Drug Delivery Devices Market, Russia, Volume (Units), Historic, 2009-2016 22
- Figure 9: Drug Delivery Devices Market, Russia, Volume (Units), Forecast, 2016-2023 24
- Figure 10: Drug Delivery Devices Market, Russia, Company Share (%) 2016 26
- Figure 11: Central Venous Catheters Market, Russia, Revenue Mix ($m), 2016 28
- Figure 12: Central Venous Catheters Market, Russia, Segment Contribution (%), 2016 29
- Figure 13: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 30
- Figure 14: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 32
- Figure 15: Central Venous Catheters Market, Russia, Volume (Units), Historic, 2009-2016 34
- Figure 16: Central Venous Catheters Market, Russia, Volume (Units), Forecast, 2016-2023 36
- Figure 17: Central Venous Catheters Market, Russia, Company Share (%) 2016 39
- Figure 18: Infusion Systems Market, Russia, Revenue Mix ($m), 2016 41
- Figure 19: Infusion Systems Market, Russia, Segment Contribution (%), 2016 42
- Figure 20: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 43
- Figure 21: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 45
- Figure 22: Central Venous Catheters Market, Russia, Volume (Units), Historic, 2009-2016 47
- Figure 23: Central Venous Catheters Market, Russia, Volume (Units), Forecast, 2016-2023 49
- Figure 24: Central Venous Catheters Market, Russia, Company Share (%) 2016 52
- Figure 25: Metered Dose Inhaler Devices Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 54
- Figure 26: Metered Dose Inhaler Devices Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 55
- Figure 27: Metered Dose Inhaler Devices Market, Russia, Volume (Units), Historic, 2009-2016 56
- Figure 28: Metered Dose Inhaler Devices Market, Russia, Volume (Units), Forecast, 2016-2023 57
- Figure 29: Metered Dose Inhaler Devices Market, Russia, Company Share (%) 2016 59
- Figure 30: Needle Free Injections Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 61
- Figure 31: Needle Free Injections Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 62
- Figure 32: Needle Free Injections Market, Russia, Volume (Units), Historic, 2009-2016 63
- Figure 33: Needle Free Injections Market, Russia, Volume (Units), Forecast, 2016-2023 64
- Figure 34: Needle Free Injections Market, Russia, Company Share (%) 2016 66